Timothy J Bell - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer|July 23, 2020

A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapyCaitlyn T Solem, Timothy J Bell, Youngmin Kwon, et al.

Oncology and Therapy|June 13, 2022

Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-MakingThomas W LeBlanc, Nigel H Russell, Loriana Hernandez-Aldama, et al.

Conservation Biology : the Journal of the Society for Conservation Biology|November 22, 2018

Effects of life history and reproduction on recruitment time lags in reintroductions of rare plantsMatthew A Albrecht, Oyomoare L Osazuwa-Peters, Joyce Maschinski, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer|July 23, 2020

A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapyCaitlyn T Solem, Timothy J Bell, Youngmin Kwon, et al.

Oncology and Therapy|June 13, 2022

Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-MakingThomas W LeBlanc, Nigel H Russell, Loriana Hernandez-Aldama, et al.

Conservation Biology : the Journal of the Society for Conservation Biology|November 22, 2018

Effects of life history and reproduction on recruitment time lags in reintroductions of rare plantsMatthew A Albrecht, Oyomoare L Osazuwa-Peters, Joyce Maschinski, et al.

Pageof 2